These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 31105041)

  • 21. How antigen specificity directs regulatory T-cell function: self, foreign and engineered specificity.
    Hoeppli RE; MacDonald KG; Levings MK; Cook L
    HLA; 2016 Jul; 88(1-2):3-13. PubMed ID: 27256587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD137+CD154- Expression As a Regulatory T Cell (Treg)-Specific Activation Signature for Identification and Sorting of Stable Human Tregs from
    Nowak A; Lock D; Bacher P; Hohnstein T; Vogt K; Gottfreund J; Giehr P; Polansky JK; Sawitzki B; Kaiser A; Walter J; Scheffold A
    Front Immunol; 2018; 9():199. PubMed ID: 29467769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigen-Specific Regulatory T Cell Therapy in Autoimmune Diseases and Transplantation.
    Selck C; Dominguez-Villar M
    Front Immunol; 2021; 12():661875. PubMed ID: 34054826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Building a CAR-Treg: Going from the basic to the luxury model.
    Rosado-Sánchez I; Levings MK
    Cell Immunol; 2020 Dec; 358():104220. PubMed ID: 33096321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigen-specificity using chimeric antigen receptors: the future of regulatory T-cell therapy?
    Boardman D; Maher J; Lechler R; Smyth L; Lombardi G
    Biochem Soc Trans; 2016 Apr; 44(2):342-8. PubMed ID: 27068938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulatory CAR-T cells in autoimmune diseases: Progress and current challenges.
    Riet T; Chmielewski M
    Front Immunol; 2022; 13():934343. PubMed ID: 36032080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are chimeric antigen receptor T cells (CAR-T cells) the future in immunotherapy for autoimmune diseases?
    Santamaria-Alza Y; Vasquez G
    Inflamm Res; 2021 Jun; 70(6):651-663. PubMed ID: 34018005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human regulatory T cells: role in autoimmune disease and therapeutic opportunities.
    Brusko TM; Putnam AL; Bluestone JA
    Immunol Rev; 2008 Jun; 223():371-90. PubMed ID: 18613848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CAR- and TRuC-redirected regulatory T cells differ in capacity to control adaptive immunity to FVIII.
    Rana J; Perry DJ; Kumar SRP; Muñoz-Melero M; Saboungi R; Brusko TM; Biswas M
    Mol Ther; 2021 Sep; 29(9):2660-2676. PubMed ID: 33940160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Foxp3, Regulatory T Cell, and Autoimmune Diseases.
    Tao JH; Cheng M; Tang JP; Liu Q; Pan F; Li XP
    Inflammation; 2017 Feb; 40(1):328-339. PubMed ID: 27882473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigen-specific regulatory T cells: are police CARs the answer?
    Dawson NAJ; Levings MK
    Transl Res; 2017 Sep; 187():53-58. PubMed ID: 28688236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulatory T cells: from the bench to the clinic and back.
    Al Dulaijan BS; Mansouri A; Karnyski J; Azzi J
    Curr Opin Organ Transplant; 2018 Feb; 23(1):1-7. PubMed ID: 29210727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Driving CARs to BARs: The Winding Road to Specific Regulatory T Cells for Tolerance.
    Scott DW
    Front Immunol; 2021; 12():742719. PubMed ID: 34552599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Vitro Tailoring of Regulatory T Cells Prior to Cell Therapy.
    Baeten P; Hellings N; Broux B
    Trends Mol Med; 2020 Nov; 26(11):1059-1060. PubMed ID: 32978063
    [No Abstract]   [Full Text] [Related]  

  • 35. Manipulating regulatory T cells: a promising strategy to treat autoimmunity.
    Zhang D; Tu E; Kasagi S; Zanvit P; Chen Q; Chen W
    Immunotherapy; 2015; 7(11):1201-11. PubMed ID: 26568117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4+CD25+ regulatory T-cell therapy for allergy, autoimmune disease and transplant rejection.
    Jiang S; Lechler RI
    Inflamm Allergy Drug Targets; 2006 Dec; 5(4):239-42. PubMed ID: 17168794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells.
    Kumar P; Saini S; Khan S; Surendra Lele S; Prabhakar BS
    Cell Immunol; 2019 May; 339():41-49. PubMed ID: 30482489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanoparticle-based autoimmune disease therapy.
    Serra P; Santamaria P
    Clin Immunol; 2015 Sep; 160(1):3-13. PubMed ID: 25704658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulatory T-cell adoptive immunotherapy: potential for treatment of autoimmunity.
    Wright GP; Ehrenstein MR; Stauss HJ
    Expert Rev Clin Immunol; 2011 Mar; 7(2):213-25. PubMed ID: 21426259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic potential of regulatory T cells in autoimmune disorders.
    Fessler J; Felber A; Duftner C; Dejaco C
    BioDrugs; 2013 Aug; 27(4):281-91. PubMed ID: 23580095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.